Print This Page
Tissue Procurement
Tissue Procurement serves the traditional role of providing anonymous fresh and frozen tissue to investigators requiring unfixed human tissue. There are two major changes: (1) Tissue Procurement is making the necessary changes to transform a majority of requests to a macromolecule delivery (DNA, RNA, protein), allowing for a more efficient use of these precious materials by other CCSG Resources such as Microarray and Genomics and allowing multiple investigators to utilize a single specimen; (2) a procurement mechanism is being established to allow for special collections of tissues with an emphasis on translational research.
Tissue Procurement provides tissue resources to investigators with an IRB-approved protocol that require fresh or frozen remnant human tissue for research. A standardized quality control of all tissue is performed before frozen tissue is released to investigators. For fresh tissue, quality control is performed within a few days of delivery and the investigator is informed promptly of these results. Tissue Procurement is developing a macromolecule (DNA, RNA, protein) resource as the primary mode of responding to requests for this service.
